Skip to main content
Premium Trial:

Request an Annual Quote

GSK and ViroLogic Pen $7.5M Supply Deal for HIV Drug Development

NEW YORK, Feb. 3 (GenomeWeb News) - ViroLogic and GlaxoSmithKline have signed a 3-year, $7.5 million service agreement in which ViroLogic will provide its PhenoSense HIV co-receptor tropism assay for use in the drug giant's discovery and development efforts, the companies said today.

 

Glaxo will use PhenoSense in its entry-inhibitor drug program, and other virologic efforts, to identify patients for clinical trials and monitor drug treatment response during trials, the companies said.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.